Table 3 ATX cut-off distribution in HCV and control: it showed that 100% of control subjects had ATX > 97.5 and 58.8% of HCV had ATX ≤ 97.5; a difference which is statistically significant
From: Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
| ATX | Group | χ2 | P | |
|---|---|---|---|---|
|
Control (n = 20) |
HCV (n = 34) | |||
| > 97.5 | 20 (100%) | 14 (41.2%) | 18.685 | < 0.0005 |
| ≤ 97.5 | 0 (0%) | 20 (58.8%) | ||